Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.

Rosenblum H, Castano A, Alvarez J, Goldsmith J, Helmke S, Maurer MS.

Circ Heart Fail. 2018 Apr;11(4):e004769. doi: 10.1161/CIRCHEARTFAILURE.117.004769.

PMID:
29615436
2.

Myocardial Contraction Fraction: A Volumetric Measure of Myocardial Shortening Analogous to Strain.

Matthews SD, Rubin J, Cohen LP, Maurer MS.

J Am Coll Cardiol. 2018 Jan 16;71(2):255-256. doi: 10.1016/j.jacc.2017.09.1157. No abstract available.

PMID:
29325647
3.

More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac Amyloidosis.

Maurer MS, Ruberg FL, Weinsaft JW.

J Card Fail. 2018 Feb;24(2):87-89. doi: 10.1016/j.cardfail.2017.12.006. Epub 2018 Jan 3. No abstract available.

PMID:
29305971
4.

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).

O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM.

Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.

PMID:
29191938
5.

Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.

Wenger NK, Doherty CL, Gurwitz JH, Hirsch GA, Holmes HM, Maurer MS, Murray MD.

Drugs Aging. 2017 Nov;34(11):803-810. doi: 10.1007/s40266-017-0494-2.

PMID:
29110264
6.

Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.

Castaño A, Manson DK, Maurer MS, Bokhari S.

Curr Cardiovasc Risk Rep. 2017 Jun;11. pii: 17. doi: 10.1007/s12170-017-0541-x. Epub 2017 Apr 25.

PMID:
29057029
7.

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Castaño A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, George I, Kodali S, Leon MB, Hahn R, Bokhari S, Maurer MS.

Eur Heart J. 2017 Oct 7;38(38):2879-2887. doi: 10.1093/eurheartj/ehx350.

PMID:
29019612
8.

Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?

Maurer MS, Horn E, Reyentovich A, Dickson VV, Pinney S, Goldwater D, Goldstein NE, Jimenez O, Teruya S, Goldsmith J, Helmke S, Yuzefpolskaya M, Reeves GR.

J Am Geriatr Soc. 2017 Nov;65(11):2383-2390. doi: 10.1111/jgs.15124. Epub 2017 Sep 21.

PMID:
28940248
9.

Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?

Rubin J, Alvarez J, Teruya S, Castano A, Lehman RA, Weidenbaum M, Geller JA, Helmke S, Maurer MS.

Amyloid. 2017 Dec;24(4):226-230. doi: 10.1080/13506129.2017.1375908. Epub 2017 Sep 14.

PMID:
28906148
10.

Gerontechnologies for Older Patients with Heart Failure: What is the Role of Smartphones, Tablets, and Remote Monitoring Devices in Improving Symptom Monitoring and Self-Care Management?

Masterson Creber RM, Hickey KT, Maurer MS.

Curr Cardiovasc Risk Rep. 2016 Oct;10(10). pii: 30. doi: 10.1007/s12170-016-0511-8. Epub 2016 Aug 15.

11.

Contextualizing Myocardial Infarction: Comorbidities and Priorities in Older Adults.

Krishnaswami A, Maurer MS, Alexander KP.

Am J Med. 2017 Oct;130(10):1144-1147. doi: 10.1016/j.amjmed.2017.05.043. Epub 2017 Jul 4. Review.

PMID:
28687265
12.

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).

Maurer MS, Elliott P, Merlini G, Shah SJ, Cruz MW, Flynn A, Gundapaneni B, Hahn C, Riley S, Schwartz J, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

Circ Heart Fail. 2017 Jun;10(6). pii: e003815. doi: 10.1161/CIRCHEARTFAILURE.116.003815. Review.

PMID:
28611125
13.

Salt Taste Recognition in a Heart Failure Cohort.

Cohen LP, Hummel SL, Maurer MS, López-Pintado S, Wessler JD.

J Card Fail. 2017 Jul;23(7):538-544. doi: 10.1016/j.cardfail.2017.05.001. Epub 2017 May 10.

PMID:
28499978
14.

Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.

Edwards CV, Gould J, Langer AL, Mapara M, Radhakrishnan J, Maurer MS, Raza S, Mears JG, Wall J, Solomon A, Lentzsch S.

Amyloid. 2017 Mar;24(sup1):58-59. doi: 10.1080/13506129.2017.1292900. No abstract available.

PMID:
28434347
15.

Deactivation of Ventricular Assist Devices: Perspectives and Experiences of Adult Cardiovascular Providers.

Blume ED, Hauptman PJ, Gauvreau K, Cooper S, Goodlin S, Swetz KM, Alpert C, Hummel SL, Josephson RA, Doherty C, Brenes Salazar J, Maurer MS, Cestoni A, Bohannon K, Light-McGroary KA, Kirkpatrick JN.

J Card Fail. 2017 Jun;23(6):485-486. doi: 10.1016/j.cardfail.2017.04.008. Epub 2017 Apr 19. No abstract available.

PMID:
28433668
16.

Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness.

Baldwin MR, Singer JP, Huang D, Sell J, Gonzalez WC, Pollack LR, Maurer MS, D'Ovidio FF, Bacchetta M, Sonett JR, Arcasoy SM, Shah L, Robbins H, Hays SR, Kukreja J, Greenland JR, Shah RJ, Leard L, Morrell M, Gries C, Katz PP, Christie JD, Diamond JM, Lederer DJ.

Ann Am Thorac Soc. 2017 Aug;14(8):1270-1279. doi: 10.1513/AnnalsATS.201612-1008OC.

PMID:
28398076
17.

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).

Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T; THAOS investigators.

PLoS One. 2017 Apr 6;12(4):e0173086. doi: 10.1371/journal.pone.0173086. eCollection 2017.

18.

Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C.

Circulation. 2017 Apr 4;135(14):1357-1377. doi: 10.1161/CIRCULATIONAHA.116.024438. Review.

19.

Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.

Goyal P, Paul T, Almarzooq ZI, Peterson JC, Krishnan U, Swaminathan RV, Feldman DN, Wells MT, Karas MG, Sobol I, Maurer MS, Horn EM, Kim LK.

J Am Heart Assoc. 2017 Mar 29;6(4). pii: e003330. doi: 10.1161/JAHA.116.003330.

20.

Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness.

Baldwin MR, Sell JL, Heyden N, Javaid A, Berlin DA, Gonzalez WC, Bach PB, Maurer MS, Lovasi GS, Lederer DJ.

Crit Care Med. 2017 Jun;45(6):e583-e591. doi: 10.1097/CCM.0000000000002313.

PMID:
28333761

Supplemental Content

Loading ...
Support Center